ES516553A0 - Procedimiento para preparar nuevos derivados de etenilimidazol. - Google Patents

Procedimiento para preparar nuevos derivados de etenilimidazol.

Info

Publication number
ES516553A0
ES516553A0 ES516553A ES516553A ES516553A0 ES 516553 A0 ES516553 A0 ES 516553A0 ES 516553 A ES516553 A ES 516553A ES 516553 A ES516553 A ES 516553A ES 516553 A0 ES516553 A0 ES 516553A0
Authority
ES
Spain
Prior art keywords
carbon atoms
group
formula
ethenylimidazole
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES516553A
Other languages
English (en)
Other versions
ES8307000A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of ES516553A0 publication Critical patent/ES516553A0/es
Publication of ES8307000A1 publication Critical patent/ES8307000A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/93Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by halogen atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/94Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES516553A 1980-09-17 1982-10-15 Procedimiento para preparar nuevos derivados de etenilimidazol. Expired ES8307000A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8005204A NL8005204A (nl) 1980-09-17 1980-09-17 Ethenyl-imidazool-derivaten met antimycotische werkzaamheid.

Publications (2)

Publication Number Publication Date
ES516553A0 true ES516553A0 (es) 1983-06-16
ES8307000A1 ES8307000A1 (es) 1983-06-16

Family

ID=19835894

Family Applications (4)

Application Number Title Priority Date Filing Date
ES505563A Granted ES505563A0 (es) 1980-09-17 1981-09-17 Procedimiento para preparar nuevos derivados de etenilimida-zol
ES516553A Expired ES8307000A1 (es) 1980-09-17 1982-10-15 Procedimiento para preparar nuevos derivados de etenilimidazol.
ES516554A Granted ES516554A0 (es) 1980-09-17 1982-10-15 Procedimiento para preparar nuevos derivados de etenilimidazol.
ES516552A Granted ES516552A0 (es) 1980-09-17 1982-10-15 Procedimiento para preparar nuevos derivados de etenilimidazol.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES505563A Granted ES505563A0 (es) 1980-09-17 1981-09-17 Procedimiento para preparar nuevos derivados de etenilimida-zol

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES516554A Granted ES516554A0 (es) 1980-09-17 1982-10-15 Procedimiento para preparar nuevos derivados de etenilimidazol.
ES516552A Granted ES516552A0 (es) 1980-09-17 1982-10-15 Procedimiento para preparar nuevos derivados de etenilimidazol.

Country Status (10)

Country Link
EP (1) EP0049913B1 (es)
JP (1) JPS6030673B2 (es)
AT (1) ATE18667T1 (es)
DE (1) DE3174132D1 (es)
DK (1) DK412581A (es)
ES (4) ES505563A0 (es)
GR (1) GR75347B (es)
IE (1) IE52055B1 (es)
NL (1) NL8005204A (es)
PT (1) PT73659B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128606B (en) * 1979-11-13 1984-10-31 Sandoz Ltd Oxiranes
GR78234B (es) * 1981-03-10 1984-09-26 Ciba Geigy Ag
CA1206970A (en) * 1981-10-01 1986-07-02 Hak-Foon Chan Substituted ethylenic imidazoles and triazoles
DE3139251A1 (de) * 1981-10-02 1983-04-21 Basf Ag, 6700 Ludwigshafen Mittel zur regulierung des pflanzenwachstums
EP0091503A1 (en) * 1982-04-14 1983-10-19 Gist-Brocades N.V. Process of combatting fungal infections
US4539325A (en) * 1983-11-07 1985-09-03 Janssen Pharmaceutica N.V. 1-(2-Aryl-2-halo-1-ethenyl)-1H-azoles, and anticonvulsant use thereof
GB8511344D0 (en) * 1985-05-03 1985-06-12 Ici Plc Heterocyclic compounds
JPS6348214A (ja) * 1986-08-18 1988-02-29 Morishita Seiyaku Kk 1−〔2−(2,4−ジクロロフエニル)−3−メチル−1−ペンテニル〕−1h−イミダゾ−ルを含有する水中油型脂肪乳剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1486817A (fr) * 1965-07-22 1967-06-30 Basf Ag Insecticides
NL7110875A (es) * 1970-08-13 1972-02-15
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
IT1098864B (it) * 1978-09-19 1985-09-18 Farchemia Spa Processo per la preparazione di nitroimidazoli

Also Published As

Publication number Publication date
ATE18667T1 (de) 1986-04-15
EP0049913B1 (en) 1986-03-19
EP0049913A3 (en) 1982-10-06
ES8307001A1 (es) 1983-06-16
EP0049913A2 (en) 1982-04-21
ES8307000A1 (es) 1983-06-16
ES516554A0 (es) 1983-06-16
ES8306999A1 (es) 1983-06-16
ES8305729A1 (es) 1983-04-16
DE3174132D1 (en) 1986-04-24
DK412581A (da) 1982-03-18
ES516552A0 (es) 1983-06-16
JPS5781469A (en) 1982-05-21
NL8005204A (nl) 1982-04-16
GR75347B (es) 1984-07-13
JPS6030673B2 (ja) 1985-07-17
IE52055B1 (en) 1987-05-27
PT73659A (en) 1981-10-01
PT73659B (en) 1985-06-28
ES505563A0 (es) 1983-04-16
IE812146L (en) 1982-03-17

Similar Documents

Publication Publication Date Title
ES2059069T3 (es) Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion.
ES2039221T3 (es) Procedimiento para producir derivados de piridazinona.
ES516553A0 (es) Procedimiento para preparar nuevos derivados de etenilimidazol.
IL58256A (en) N-pyrrolyl-pyridazineamines,process for their manufacture and antihypertensive compositions containing them
ATE75737T1 (de) Indenothiazolderivate und verfahren zu ihrer herstellung.
DE3375917D1 (en) Thiomethylpyridine derivatives, process for their preparation and medicaments containing them
HUT43787A (en) Process for production of medical compounds decreasing blood-pressure
DE3667788D1 (de) Diphenyletherherbizide.
BR8401710A (pt) Processo para a preparacao de fenetilsulfonamidas n-sulfeniladas,composicoes praguicidas e processos para o combate as pragas e para a preparacao de composicoes
ATE30911T1 (de) Hydrazinopyridazinverbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
FR2566407B1 (fr) Nouveaux derives de l'isoxazoloquinoleine, procede de preparation, application a titre de medicaments, et compositions les renfermant
ATE17710T1 (de) Keten-0,0-acetale und verfahren zu ihrer herstellung.
ES8105286A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina.